Geron
GERN
#7210
Rank
โ‚ฌ0.51 B
Marketcap
0,79ย โ‚ฌ
Share price
-4.63%
Change (1 day)
-18.38%
Change (1 year)

EPS for Geron (GERN)

EPS in 2026 (TTM): -0,06873ย โ‚ฌ

According to Geron's latest financial reports the company's current EPS (TTM) is -0,07293ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,12ย โ‚ฌ an increase over its 2024 EPS that were of -0,25ย โ‚ฌ.

EPS history for Geron from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,06873ย โ‚ฌ-42.01%
2025-0,12ย โ‚ฌ-51.85%
2024-0,25ย โ‚ฌ-18.18%
2023-0,30ย โ‚ฌ-8.33%
2022-0,33ย โ‚ฌ-0%
2021-0,33ย โ‚ฌ33.33%
2020-0,25ย โ‚ฌ-25%
2019-0,33ย โ‚ฌ140%
2018-0,14ย โ‚ฌ-16.67%
2017-0,16ย โ‚ฌ-0%
2016-0,16ย โ‚ฌ-1.2970366926827E+18%
20150,0000000000ย โ‚ฌ-100%
2014-0,22ย โ‚ฌ
2012-0,49ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-2,83ย โ‚ฌ 3,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
1,91ย โ‚ฌ-2,725.00%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-0,53ย โ‚ฌ 625.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
1,07ย โ‚ฌ-1,562.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-26,70ย โ‚ฌ 36,512.50%๐Ÿ‡บ๐Ÿ‡ธ USA